Search results for " Control"

showing 10 items of 7691 documents

Methodological matters on an Alzheimer's dementia trial: is a double-blind randomized controlled study design sufficient to draw strong conclusions o…

2007

medicine.medical_specialtybusiness.industryGinkgo bilobamedicine.diseaselaw.inventionDouble blindNeurologyRandomized controlled trialDouble-Blind MethodPiperidineslawAlzheimer DiseaseIndansmedicineDementiaHumansAlzheimer s dementiaDementiaDonepezilNeurology (clinical)Cholinesterase InhibitorsPsychiatrybusinessRandomized Controlled Trials as TopicEuropean journal of neurology
researchProduct

Energy spectral density as valid parameter to compare postural control between subjects with nonspecific chronic low back pain vs healthy subjects : …

2021

Abstract Background Nonspecific chronic low back pain (NSCLBP) is one of the most common and frequent health problems. Objetive to compare postural control (i.e. center of pressure (CoP) displacement and energy spectral density (ESD)) using technological devices (accelerometers and pressure platform) between subjects with NSCLBP and healthy subjects. Methods A cross-sectional case-control study was conducted. Observational study (STROBE). The final sample consisted of 60 subjects (30 NSCLBP subjects and 30 healthy subjects). Triaxial accelerometer and pressure platform were used in order to obtain ESD and CoP displacement measurements during four balance tasks (i.e. with and without vision …

medicine.medical_specialtybusiness.industryHealthy subjectsCase-control studyPhysical Therapy Sports Therapy and RehabilitationCase-control studiesAccelerometerDisplacement (psychology)Healthy VolunteersPostural control03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationCross-Sectional StudiesMultivariate analysis of variancemedicineHumans030212 general & internal medicineHuman medicinebusinessLow Back Pain030217 neurology & neurosurgerypostural balanceCenter of pressure (fluid mechanics)Balance (ability)Musculoskeletal science & practice
researchProduct

Randomized Trial of Lenalidomide and Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Mul…

2019

Continuous treatment with lenalidomide (R) and dexamethasone (d) is a standard of care for multiple myeloma (MM) patients (pts) not candidates for autologous stem cell transplantation (ASCT). As previously reported, the addition of Clarithromycin (C) to Rd has proven to be safe and effective, and case-control analyses suggested a significant additive value with the combination. C optimizes the therapeutic effect of glucocorticoids by increasing the area under the curve, has immunomodulatory effects and may have direct antineoplastic properties. However, there are not randomized phase III trials confirming these results. GEM-Claridex in an open, randomized, phase III trial for untreated new…

medicine.medical_specialtybusiness.industryImmunologyDisease progressionCell BiologyHematologymedicine.diseaseBiochemistrylaw.inventionTransplantationClinical trialAutologous stem-cell transplantationRandomized controlled triallawInternal medicinemedicineIn patientbusinessMultiple myelomaLenalidomidemedicine.drugBlood
researchProduct

Rituximab in Combination with CHOP in Patients with Follicular Lymphoma: Analysis of Treatment Outcome of 552 Patients Treated in a Randomized Trial …

2008

Abstract We have previously reported that compared to CHOP alone the addition of Rituximab (R) to CHOP significantly increases the response rate (RR), the time to treatment failure (TTF) and also the overall survival (OS) in patients with newly diagnosed advanced follicular lymphoma. However, in the previous report, the median observation time was short with 18 months and no data were reported on the outcome of different risk groups according to the FLIPI (Hiddemann et al., Blood 2005). We now report on the treatment outcome of 552 patients with advanced stage follicular lymphoma randomized between R-CHOP versus CHOP alone after a median follow up of 58 months. Responding patients < …

medicine.medical_specialtybusiness.industryImmunologyFollicular lymphomaAlpha interferonCell BiologyHematologyCHOPDebulkingmedicine.diseaseBiochemistryChemotherapy regimenGastroenterologySurgerylaw.inventionRandomized controlled trialMedian follow-uplawInternal medicinemedicineRituximabbusinessmedicine.drugBlood
researchProduct

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria

2016

medicine.medical_specialtybusiness.industryImmunologyQuilizumablaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemRandomized controlled trialRefractorylawInternal medicineImmunology and AllergyMedicinebusinessJournal of Allergy and Clinical Immunology
researchProduct

Responsiveness and minimal important difference of the urticaria control test

2017

This study demonstrates the responsiveness of the Urticaria Control Test (UCT). Changes of its score by 3 points or more reflect a clinically relevant change of disease control (minimal important difference).

medicine.medical_specialtybusiness.industryImmunologyTreatment outcomeOmalizumabDisease controlDisease activity030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChronic disease030228 respiratory systemQuality of lifeControl testInternal medicineSeverity of illnessmedicinePhysical therapyImmunology and Allergysense organsskin and connective tissue diseasesbusinessmedicine.drugJournal of Allergy and Clinical Immunology
researchProduct

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial C…

2020

Background Since the FDA approval of clofarabine for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL) at childhood, several studies have been launched which put clofarabine under scrutiny in combination with other cytostatic drugs as second or third line therapy. As a novel treatment-strategy we introduced the combination of clofarabine with pegylated asparaginase (PEG-ASP) in a randomized fashion in comparison to the standard consolidation course with high dose cytarabine (Hidac) combined with PEG-ASP into the frontline management of ALL within the CoALL 08-09 protocol. The primary objective of the study was to compare the MRD based assessment of the cytotoxic eff…

medicine.medical_specialtybusiness.industryImmunologyUrologyCell BiologyHematologyBiochemistryMinimal residual diseaselaw.inventionHigh dose cytarabineRandomized controlled triallawmedicineClofarabinebusinessmedicine.drugBlood
researchProduct

Incidence of mandibular fractures in eastern Libya

2009

The objective of this retrospective study is to evaluate the incidence of mandibular fractures in the eastern part of Libya and to present our experience in treating this type of facial fracture. We analyzed factors such as the incidence of age, sex, time distribution, cause and site of the fracture and the associated injuries in 493 patients presenting a total of 666 mandibular fractures. These patients were treated at Al-Jala Trauma Hospital, Benghazi-Libya between 2000 and 2006. The results were obtained from 432 males and 61 females, for which the ages ranged from 8 months to 72 years. The maximum number of the patients was recorded in 2004, and the busiest month was May. The most commo…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)Developing countryPoison controlRetrospective cohort study:CIENCIAS MÉDICAS [UNESCO]Occupational safety and healthSurgeryOtorhinolaryngologyInjury preventionUNESCO::CIENCIAS MÉDICASmedicineSurgeryYoung adultbusinessGeneral DentistrySocioeconomic statusDemography
researchProduct

WITHDRAWN: Stability of cerebral activation patterns in patients with first-episode schizophrenia and a healthy control group using functional MRI

2011

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

medicine.medical_specialtybusiness.industryInternal medicineHealthy controlMedicineRadiology Nuclear Medicine and imagingIn patientGeneral MedicineFirst episode schizophreniabusinessEuropean Journal of Radiology
researchProduct

Cardiovascular consequences of sleep disordered breathing: the role of CPAP treatment

2020

CPAP treatment decreases BP in OSA patients, especially in severe OSA, and in patients with poorly controlled BP. OSA adversely affects heart function and remodelling, but its role in the pathogenesis of HF remains unclear. Similarly, the impact of CPAP is uncertain, and results of the ongoing ADVENT-HF trial will provide more information. Several experimental studies in animals and humans indicate a central role of intermittent hypoxia in atherogenesis through multiple mechanisms. However, randomised controlled trials (RCTs) in patients with CAD and OSA found no difference in outcomes between CPAP-treated and untreated patients. The negative results of secondary prevention RCTs may be the …

medicine.medical_specialtybusiness.industryInternal medicinerandomized controlled trialsSleep disordered breathingCardiologyblood pressureMedicineCpap treatmentSettore MED/10 - Malattie Dell'Apparato Respiratorioarrhythmiabusiness
researchProduct